Objective: To identify between and within profession-rater reliability of clinical impact grading for common critical care prescribing error and optimisation cases. To identify representative clinical impact grades for each individual case. Design: Electronic questionnaire. Setting: 5 UK NHS Trusts. Participants: 30 Critical care healthcare professionals (doctors, pharmacists and nurses). Intervention: Participants graded severity of clinical impact (5-point categorical scale) of 50 error and 55 optimisation cases. Main Outcome Measures: Case between and within profession-rater reliability and modal clinical impact grading. Methods: Between and within profession rater reliability analysis used linear mixed model and intraclass correlation, respectively. Results: The majority of error and optimisation cases (both 76%) had a modal clinical severity grade of moderate or higher. Error cases: doctors graded clinical impact significantly lower than pharmacists (−0.25; P < 0.001) and nurses (−0.53; P < 0.001), with nurses significantly higher than pharmacists (0.28; P < 0.001). Optimisation cases: doctors graded clinical impact significantly lower than nurses and pharmacists (−0.39 and −0.5; P < 0.001, respectively). Within profession reliability grading was excellent for pharmacists (0.88 and 0.89; P < 0.001) and doctors (0.79 and 0.83; P < 0.001) but only fair to good for nurses (0.43 and 0.74; P < 0.001), for optimisation and error cases, respectively. Conclusions: Representative clinical impact grades for over 100 common prescribing error and optimisation cases are reported for potential clinical practice and research application. The between professional variability highlights the importance of multidisciplinary perspectives in assessment of medication error and optimisation cases in clinical practice and research.
Introduction
Medication therapy is a cornerstone of care of the critically ill patient with medication exposure rates double those seen in wardbased patients [1] . The additional complexity of clinical care for critically ill patients and the prevalent use of high risk medications [2] , means that medication review to minimise errors and optimise use of prescribed medicines, is fundamental to the delivery of safe and effective medication therapy.
Medication errors are very common in critically ill patients [2] , and significant efforts are therefore employed by intensive care units (ICUs) to reduce their occurrence and adverse clinical impact. Although a range of interventions have been demonstrated to reduce medication errors [3] , it remains unknown how individual interventions or combinations thereof, affect patient outcomes. As a result interventions are inconsistently applied across different ICUs, with implications for their efficacy and resource use. This position may in part be due to uncertainty of the strength of the direct relationship between medication errors and preventable adverse drug events (ADEs) [4] . Whilst adverse events, including those caused by medicines, have a direct relationship with patient outcomes [5] , the potential clinical impact of individual medication errors remain less clear. This uncertainty may in part be due lack of assessment of the potential clinical severity arising from different medication errors and has implications for clinical practice and research.
In clinical practice, a robust critical incident reporting and response system is an important intervention in improving medicines safety in critical care patients [3] . This reporting is often based on a clinical risk matrix incorporating factors for clinical impact and occurrence likelihood. As such, an individual's subjective assessment of the clinical impact of a medication error can produce inconsistencies in the risk assessment and ultimately the unit response. In research, it is also recommended that when assessing the effects of interventions on medication error rates, that the clinical severity and significance of the error should also be considered [6] . Recent multicentre studies examining prescribing errors in critically ill patients [7] , and hospital-wide [8] , have utilised research panels to subjectively grade the clinical impact of medication errors. The composition of these panels are often multiprofessional [7, 8] . Also within these panels, it is important to have exemplars of agreed clinical impact grading of common medication errors and optimisations made in ICU patients for use in clinical practice and to facilitate research in this field.
The objectives of the study were to identify the between and within profession-rater reliability of clinical impact grading for common prescribing error and optimisation cases in critical care patients. Secondly to identify representative clinical impact grades for each individual case in order to facilitate application of severity scoring in future clinical practice and research.
Methods
Prescribing errors and optimisations from the PROTECTED UK [7] study were analysed with a view to producing a list of errors and optimisations for subsequent classification by critical care healthcare professionals. Although the term medicines optimisation now refers to a review process to achieve the best patient outcomes with medicines [9] , we chose to separate error and optimisation cases (nonerror), as error cases are a more recognised metric of medication therapy by healthcare providers. A medication error was defined as an error in the process of prescribing, dispensing, preparing, administering, monitoring or providing medicine advice, regardless of whether harm had occurred [7] . Optimisation was defined as a proactive contribution to medication therapy that sought to enhance patient care [7] . Errors and optimisation cases were sorted by reported type, then frequency of the medication involved. Similar medicines likely to demonstrate unit specific choices were combined (e.g. dalteparin, enoxaparin and tinzaparin were combined as low molecular weight heparins, chlorhexidine dental gel and mouthwash as chlorhexidine oral decontamination and lansoprazole, pantoprazole and omperazole as proton pump inhibitors). The five most common medicines for each error/optimisation case type were identified. If there were multiple examples for a class of medication (e.g. antibiotics) a single representative example was chosen (e.g. piperacillintazobactam). A total of 50 medication errors and 55 medication optimisation cases were identified in this manner and used as representative examples of actual clinical scenarios extracted from the PROTECTED UK study database. Two of the authors (RSB and RS) then re-reviewed the example cases to ensure sufficient clinical data were included in the original description and re-worded the text to make it more understandable for the variety of multidisciplinary practitioners who would be grading the impact. For example, the term 'practitioner' was used throughout to indicate that the error or optimisation case may have been made by any healthcare professional as part of a medication review.
The resulting 50 medication errors and 55 medication optimisation case descriptions were sent to a purposive sample of 30 critical care healthcare professionals (10 of each: ICU consultants, specialist pharmacists and specialist nurses). ICU Consultants were defined as a medical consultant in intensive care with a minimum of 3 years experience at consultant level [10] . Specialist clinical pharmacists are defined as clinical pharmacists deemed to be working at advanced level practice in critical care according to national criteria [11] . Specialist nurses are defined as a nurse with a critical care postgraduate qualification, working as an advanced nurse practitioner or having a minimum of 10 years post-qualification critical care experience. Participants ('raters') were recruited from five sites that participated in the PROTECTED UK study [7] . The finalised cases were then incorporated into two (error and optimisation cases) Survey Monkey (Survey Monkey Inc., California, USA: www. surveymonkey.com) questionnaires and piloted in six participants (two of each profession) in one centre to ensure the language, terminology and the survey procedures were appropriate. Each rater was asked to grade the case for potential severity of patient harm if the error/ optimisation had occurred. A 5-point categorical scale (0 = no clinical impact to 4 = life threatening/saving clinical impact) was used to grade all cases. All rater responses were annonymised except for their health professional designation and duration of practice at that designated level.
The study was sponsored by Sheffield Teaching Hospitals NHS Foundation Trust (registered with the sponsor as STH 18573) and received favourable NHS external independent scientific review prior to proceeding. In line with GAfREC 2011 NHS REC review was not required as the research involved only NHS staff who were recruited by virtue of their professional role. Each of the five NHS sites R&D Departments gave NHS permission for the study.
Statistical analysis
Simple descriptive statistics were used to rate the modal clinical impact grade for each medication error or optimisation case. If multiple modes were recorded the lowest severity grade was reported.
Measures of reliability were examined between and within professional groups. Between profession rater reliability was tested using a linear mixed model where the grade and assessor were nested within profession and used profession as the explanatory variable, with the case included as a random effect. Within profession rater reliability was tested using the intraclass correlation with a two-way random effects model using absolute agreement [12] . Participants not completing all case grading were excluded from within profession rater reliability testing. Data were analysed using SPSS 22.0 software (IBM Corp, New York, USA). All results P < 0.05 were deemed statistically significant.
Results

Participants
Overall, 30 participants were enroled (10 from each profession) across five UK units (Sheffield Teaching Hospitals NHS Foundation Trust, University College London Hospital NHS Foundation Trust, University Hospital Southampton NHS Foundation Trust, Guys and St Thomas' NHS Foundation Trust and Oxford University Hospitals NHS Foundation Trust) ( Table 1 ). All 10 ICU Consultants ('Doctors') and Specialist Critical Care Pharmacists ('Pharmacists') completed all error and optimisation cases. Nine Specialist Critical Care Nurses ('Nurses') completed the error cases grading and eight completed the optimisation cases grading. Furthermore, not all nurses completed ratings for each full question set. Only six of the nine nurses graded all the error cases and six of the eight nurses graded all optimisation cases.
Severity grade
Modal results for each error and optimisation case are made available (see electronic Supplementary file).
Overall, the modal clinical severity grade distribution of the example cases showed a very similar distribution pattern between error and optimisation cases; with the majority (>75% for both groups) graded as moderate severity grade or above (Table 2) .
Between professions rater reliability (i) Error cases
There was a statistically significant difference between all three professions, with nurses showing the highest measurements on average, doctors showing the lowest measurements on average and pharmacists showing lower measurements than the nurses but higher measurements than the doctors. On average nurses assessed that the level of error was half a grade higher than doctors, while pharmacists assessed that the level of error is about a quarter of a grade higher than the doctors (a quarter of a grade lower than the nurses) (Tables 3 and 4-Errors). Despite the statistical significant differences in average case grades between the professional groups, the actual grading differences are likely to be less clinically significant.
(ii) Optimisation cases There was a significant difference between Doctors and the Nurses or Pharmacists professional groups. Doctors reported a significantly lower grading on average being half a grade lower than the Nurse or Pharmacist groups (Tables 3 and 4 -Optimisation cases). Again as average grades between professional groups differed by less than one grade the clinical significance of these differences are likely to be limited.
Within profession rater reliability
Doctors and Pharmacists demonstrated excellent within profession rater-reliability of grading of error and optimisation cases. Nurses had good rater reliability for grading error cases, but only fair within profession rater reliability for grading optimisation cases [13] ( Table 5) .
Discussion
This was a multicentre study conducted in UK critical care professionals of similar duration of experience, reporting the clinical impact grading that used actual examples of common medication errors and optimisations encountered in clinical practice. Results for the modal clinical impact grades for more than 100 common medication error and optimisation cases identified from clinical practice and defined by type (e.g. subtherapeutic dose) are reported. The use of actual examples of common medication error and optimisation Years of experience at the designated healthcare professional level. cases adds further value in terms of the likelihood recurrence in routine practice. To our knowledge, this is the first study that specifically focused on grading of the potential clinical impact on patients of medication optimisation cases by different healthcare professions in this specialty. The availability of the modal clinical impact grading for the medication errors provides a reference basis for use by clinical staff and researchers in this area. Clinical staff now have assistance with the risk assessment component of clinical incident reports for use at an individual critical care unit or hospital level. Researchers also benefit from having agreed clinical impact grading of errors and optimisations in future studies aimed at developing resources to improve the safe and effective use of medicines in the critically ill patient. Recent multicentre studies examining prescribing errors in critically ill patients [7] , and hospital-wide [8] , have utilised research panels to subjectively grade the clinical impact of medication errors. The composition of these panels are often multiprofessional [7, 8] and these case clinical impact grades could be used to train panel members, providing a useful reference to assist with similar cases of arbitration.
The majority of modal clinical impact gradings for the error and optimisation cases were moderate or higher. These results are in keeping with the results of the PROTECTED UK study [7] and another recent UK critical care study by Richter et al. [14] ; but contrasts with an earlier UK prescribing error study [15] , which reported most were of minor clinical severity. One important reason that there may be such variation in results could be simply down to the subjectivity of grading in the context of lack of clear understanding of the relationship between medication errors and actual patient harm (preventable ADEs). A recent integrative review of medication errors and ADEs in intensive care patients highlighted the variability in medication error rate reported in studies compounded by an unclear relationship between the errors and ADE rate [4] . There may be an assumption that as the majority of medication errors are identified before the patient is harmed [2] , their importance is limited. However, a mean of 0.9 doses had been given in one study before the errors were corrected [16] . These highlight the need to conduct further research into medication error (and optimisation) cases and the link with actual patient outcomes such as length of ICU or hospital stay and mortality rates.
The differences in clinical impact grading between the study of Ridley et al. [15] and those of Shulman et al. [7] and Richter et al. [14] may also be explained by different study dates and methodologies. In particular, differences in healthcare professional used to grade the clinical impact are notable. The studies of Shulman et al. [7] and Richter et al. [14] used pharmacists (with arbitration by a doctor) whilst Ridley et al.'s study [15] used doctors to grade the importance of medication errors. As such inter-professional assessment may be a reason for the differences reported in these UK ICU studies. We did find significant differences in clinical impact grading of error and optimisation cases between doctors and pharmacists. However, these differences were relatively small being only a quarter and half of a grade lower for doctors compared to pharmacists for the error and optimisation cases, respectively. Indeed, the importance of these differences in terms of clinical impact grade on average are minimal, with the same average clinical impact grade when figures are rounded up to whole numbers. Nevertheless, such differences do highlight differences in perception between these professions. For example, pharmacists may not always fully appreciate the context of the overall patient care plan outside of a multidisciplinary team (MDT) ward round, or medical staff may not fully appreciate the significance of a drug-drug interaction. Such differences are also likely to contribute to the reasons for the~90% (rather than 100%) action by medical staff of clinical pharmacists recommendations reported in intensive care studies [7, 17] . These potential differences highlight the importance of communication between the MDT in clinical practice. For example, the patient benefits derived from a MDT ward round [18, 19] may arise partly because it is an opportunity for different perspectives and points to be identified, discussed and resolved with a consensus plan formed. Lane et al. [20] , in a systematic review of evidence-informed practices in ICU ward rounds, identified that the quality of the ward rounds was improved when conducted by multidisciplinary healthcare providers. In research terms, a multidisciplinary panel is required when assessing the clinical importance of medication error or optimisation cases in order to ensure there is a balanced assessment of the potential implications. Nurses graded medication error cases significantly higher than doctors or pharmacists (0.5-0.25 of a grade respectively). Williams and Ashcroft [21] also reported that nurses scored medication error cases at higher clinical impact compared to doctors and pharmacists. However, that study reported the sum of the scores assigned by each profession and didn't account for variation by case or by individual assessor. Apportion of higher clinical importance may also contribute to why nurses are also more likely to report medication error cases in clinical practice than doctors [21, 22] . Perez et al. [23] took a systematic approach to understanding potential barriers to medical error reporting by one staff group (doctors), which highlights the complexity of this area of practice.
Examination of responses on an individual case basis did highlight some concerns on grading by individuals which may have clinical implications for medication reviews and patient care locally. For example, in the optimisation case (#41) in which the practitioner identified omission of antimicrobial therapy in a patient with septic shock (secondary to a urinary tract infection) and then rectified this by organising an immediate prescription and administration of maintenance doses. The modal answer was 'life threatening,' which is very much in line with the current understanding of the importance of appropriate antimicrobial therapy in sepsis [24] , although a quarter of participants rated as lower clinical importance, including one doctor who graded the case as 'no clinical impact. ' Within profession rater reliability was excellent for doctors and pharmacists but only good and fair for nurses in grading errors and optimisations respectively. A recent systematic review of measuring the severity of prescribing error cases highlighted a significant degree of variability by healthcare professionals using a variety of assessment tools [6] . Overall, the within profession rater reliability of the doctors and pharmacists compared favourably with the literature [6] . However, nurses appeared to find grading of optimisation cases particularly difficult (increased variability and fewer completions) and this may reflect a more limited perception of potential clinical benefits or discerning potential versus actual harm [6] . This may explain why research panels used in grading medication error cases tend to rely on the use of doctors and pharmacists [7, 25, 26] .
In this data set, optimisation cases mirrored the error cases in terms of clinical severity grade. This highlights that there is more to medication review than identifying errors-it is about improving patient care. Interventions focused specifically at reducing medication errors may therefore miss an important aspect of medication review in critically ill patients, i.e. ensuring medication therapy is effective as well as safe. In the PROTECTED UK study, clinical pharmacists made more contributions to optimise medicines use than to correct medication errors [7] . The complexity of the critically ill patient means that medication optimisation is a key component of their care. However, the effect that these optimisations have on outcome in the critically ill patient, as part of medication review processes, remains unknown. As such, it is perhaps not too surprising that there was a statistically significant difference in rater grades between some professional groups, with doctors having significantly lower grades on average (by approximately half a grade) compared to pharmacists and nurses. This remains an important research area in terms of medication review processes in the critical care patient.
Limitations
Not all nurse participants completed grading for both error and optimisation cases and not all gradings were completed. We contacted participants after enrolment to encourage completion by email and locally via the principal investigators. However, it appeared that some participants still were unable to complete the gradings. Time constraints may have impacted on this; although an estimate of time requirements were provided to participants. Nurses that completed the optimisation cases were more experienced overall.
Grades of medication error cases were not defined for the participants beyond the 5-point Likert scale descriptors as there is a wide variety of definitions used without any clear relationship with actual patient harm [6, 27] . We made no constraints on participant's experience of grading medication errors or optimisations (e.g. research experience) beyond the clinical experience stipulations. No additional resources were made available to participants to grade potential impact of clinical cases.
Unlike the study by Thomas et al. [26] , we chose not to use an edelphi process to gain consensus for two reasons. Firstly, we wanted to identify differences between and within healthcare professional in their clinical impact grading. Secondly, we judged it impractical in a relatively large scale study (number of cases and participants), with likely significant variability, would lead to a protracted consensus process. Instead we present the modal clinical impact grade for each case.
We had initially planned to use an ordinal logistic regression model to assess the inter-professional reliability. However, the proportional hazards assumption of the model failed because there was such variability between assessors, even within profession. On more than one occasion, assessors chose all five severity impact gradings for the same case.
